Swiss National Bank - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 60 filers reported holding IMMUNE DESIGN CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q3 2016$131,000
+28.4%
17,300
+38.4%
0.00%
Q2 2016$102,000
-25.0%
12,500
+14.7%
0.00%
Q1 2016$136,000
-19.5%
10,900
+29.8%
0.00%
Q4 2015$169,000
+65.7%
8,4000.0%0.00%
Q3 2015$102,000
-29.7%
8,400
+20.0%
0.00%
Q2 2015$145,0007,0000.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q1 2016
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,208,210$16,738,232,00018.66%
ProQuest Associates IV LLC 1,962,720$14,877,0004.10%
BVF INC/IL 1,200,000$9,096,0001.71%
Abingworth LLP 197,300$1,494,0001.43%
NEXTHERA CAPITAL LP 305,000$2,312,0001.42%
Cormorant Asset Management, LP 432,990$3,282,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 203,000$1,539,0000.25%
DAFNA Capital Management LLC 40,000$303,0000.21%
Monashee Investment Management LLC 50,000$379,0000.13%
Eventide Asset Management 180,000$1,364,0000.08%
View complete list of IMMUNE DESIGN CORP shareholders